US Patent Issued to Purdue Research Foundation on Nov. 11 for "Methods for synthesis of the tricyclic prostaglandin D 2 metabolite methyl ester" (Georgia Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,791, issued on Nov. 11, was assigned to Purdue Research Foundation (West Lafayette, Ind.).

"Methods for synthesis of the tricyclic prostaglandin D 2 metabolite methyl ester" was invented by Mingji Dai (Alpharetta, Ga.) and Hunter Sims (Decatur, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for the synthesis of a tricyclic-prostaglandin D2 metabolite methyl ester or a pharmaceutically acceptable salt thereof."

The patent was filed on Dec. 5, 2022, under Application No. 18/061,969.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetah...